company background image
IDXX logo

IDEXX Laboratories WBAG:IDXX Stock Report

Last Price

€399.60

Market Cap

€32.4b

7D

-3.4%

1Y

-20.6%

Updated

22 Dec, 2024

Data

Company Financials +

IDEXX Laboratories, Inc.

WBAG:IDXX Stock Report

Market Cap: €32.4b

IDXX Stock Overview

Develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. More details

IDXX fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

IDEXX Laboratories, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for IDEXX Laboratories
Historical stock prices
Current Share PriceUS$399.60
52 Week HighUS$535.60
52 Week LowUS$374.80
Beta1.37
1 Month Change-0.62%
3 Month Change-11.96%
1 Year Change-20.59%
3 Year Change-30.04%
5 Year Change70.04%
Change since IPO175.30%

Recent News & Updates

Recent updates

Shareholder Returns

IDXXAT Medical EquipmentAT Market
7D-3.4%-1.4%-1.4%
1Y-20.6%5.4%-1.6%

Return vs Industry: IDXX underperformed the Austrian Medical Equipment industry which returned 5.4% over the past year.

Return vs Market: IDXX underperformed the Austrian Market which returned -1.6% over the past year.

Price Volatility

Is IDXX's price volatile compared to industry and market?
IDXX volatility
IDXX Average Weekly Movement3.9%
Medical Equipment Industry Average Movement6.1%
Market Average Movement3.8%
10% most volatile stocks in AT Market6.2%
10% least volatile stocks in AT Market2.1%

Stable Share Price: IDXX has not had significant price volatility in the past 3 months compared to the Austrian market.

Volatility Over Time: IDXX's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198311,000Jay Mazelskywww.idexx.com

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community.

IDEXX Laboratories, Inc. Fundamentals Summary

How do IDEXX Laboratories's earnings and revenue compare to its market cap?
IDXX fundamental statistics
Market cap€32.35b
Earnings (TTM)€830.20m
Revenue (TTM)€3.68b

39.0x

P/E Ratio

8.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IDXX income statement (TTM)
RevenueUS$3.84b
Cost of RevenueUS$1.51b
Gross ProfitUS$2.33b
Other ExpensesUS$1.47b
EarningsUS$866.24m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 03, 2025

Earnings per share (EPS)10.58
Gross Margin60.72%
Net Profit Margin22.53%
Debt/Equity Ratio54.0%

How did IDXX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:58
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IDEXX Laboratories, Inc. is covered by 31 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Ishan MajumdarBaptista Research
Balaji PrasadBarclays